Diabetes Management: A diagnostic perspective

Similar documents
Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions. Insulins. Rapid Short Intermediate Long Mix

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

DIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents

Antihyperglycemic Agents in Diabetes. Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014

RPCC Pharmacy Forum. The Type 2 Diabetes Issue. Type 2 Diabetes: The Basics

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors

Table 1. Antihyperglycemic agents for use in type 2 diabetes

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions

Clinical Cases in Diabetes Management. Joseph Cook D.O.

I. General Considerations

Diabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018

What s New in Diabetes Treatment. Disclosures

FARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)

DIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0

Diabetes Medications: Oral Anti-Hyperglycemic Medications

Pharmacology. Kacy Aderhold, MSN, APRN-CNS, CMSRN

4/9/2018 HOW TO REGULATE DIABETES MEDICATIONS. By Sarah Froemsdorf MSN, RNC, CDE, FNP DISCLOSURES NONE. Diagnosis

Oral Medication for the Management of Diabetes Mechanism of. Duration of Daily Dosing Action

Diabetes Treatment Guidelines

Rhonda Eustice, PharmD, CDE. Will Power lasts about two weeks and is soluble in alcohol. Mark Twain

New Therapies for Diabetes

Diabetes Basics. Type 1 diabetes The body cannot make insulin Requires insulin injection Is not treated with oral diabetes medicines (pills)

DIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013

Diabetes Mellitus II CPG

Oral and Injectable Non-insulin Antihyperglycemic Agents

Oral and Injectable Medication Options for Diabetes Treatment

TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

Pharmacologic Agents for Treatment of Type 2 Diabetes

TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

Diabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

DM Fundamentals Class 4 Meds for Type 2

Physician Drug Reference Chart for Diabetes Antidiabetic Medications

Advanced Practice Education Associates. Endocrine

1/15/2018. Disclosures. Current Diabetes Medications. Objectives NON-INSULIN AGENTS. Diabetes Med Classes. Mealtime

How to Fight Diabetes and Win. Diabetes. Medications

Management of Type 2 Diabetes Mellitus. Heather Corn, MD, MS Endocrinology, Diabetes, and Metabolism

Wayne Gravois, MD August 6, 2017

Non-Insulin Diabetes Medications Summary

DM Fundamentals Class 4 Meds for Type 2

Pharmacology Updates. Quang T Nguyen, FACP, FACE, FTOS 11/18/17

Multiple Small Feedings of the Mind: Diabetes. Sonja K Fredrickson, MD, BC-ADM March 7, 2014

Improving Patient Outcomes with Individualized Therapy in the Management of Type 2 Diabetes

What s New in Diabetes Medications. Jena Torpin, PharmD

DIABETES RESEARCH A CLINICIAN S OVERVIEW

2018 Diabetes Summit Managing Diabetes: An Art and a Science

Insulin Initiation and Intensification. Disclosure. Objectives

Clinical Pharmacotherapeutic Applications of the American Diabetes Association Standards of Care 2018

Clinical Practice Guidelines

Jonathan Stoehr, MD PhD Endocrinology, Diabetes, Metabolism and Nutrition Virginia Mason Medical Center Seattle, WA 2012 Virginia Mason Medical

Drug Therapy in Diabetes HEATHER TINGLE UK COLLEGE OF PHARMACY, PY4

How they work and when to take them. Diabetes Medications

Diabetes Update 2018: Challenging Transitions. Patricia A. Daly, MD, FACP, FACE Medical Director for Diabetes Valley Health System

Hot Topics: The Future of Diabetes Management Cutting Edge Medication and Technology-Based Care

Type. Diabetes Drugs. A Review

Antidiabetic Agents CHAPTER BIGUANIDES

Diabetes Update 10/12/2017. Section #1 OBJECTIVE. Lab features to consider:

Diabetes Update Bryan Heart Conference September 5, 2015 Shannon Wakeley, MD. Disclosures. Objectives 9/1/2015

Diabetes Update 2018: Challenging Transitions. Patricia A. Daly, MD, FACP, FACE Medical Director for Diabetes Valley Health System

第十五章. Diabetes Mellitus

Initiating Injectable Therapy in Type 2 Diabetes

Endo 2 SLO Practice (online) Page 1 of 7

The Death of Sulfonylureas? A Review of New Diabetes Medications

Update on Therapies for Type 2 Diabetes: Angela D. Mazza, DO July 31, 2015

Intensification of Diabetic Therapy. Case studies

Very Practical Tips for Managing Type 2 Diabetes

3. Cardiovascular Disease?

What You Should Know About Diabetes. Laura Bingell RN Transition Center Nurse for MFP (607)

Drugs used in Diabetes. Dr Andrew Smith

AACE/ACE Consensus Statement American Association of Clinical Endocrinologists and American College of Endocrinology

Diabetes 2016: Strategies for achieving optimal diabetes control

What s New on the Horizon: Diabetes Medication Update

The Community Pharmacist s Role in Diabetes Treatment

Type 2 Diabetes Mellitus 2011

What s New on the Horizon: Diabetes Medication Update. Michael Shannon, MD Providence Endocrinology, Olympia WA

What s New in Type 2 Diabetes? 2018 Diabetes Updates

Type 2 Diabetes Mellitus: Update on Pharmacotherapy 04/04/18

Mae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville

The information in this guide comes from a government-funded review of research about pills for type 2 diabetes.

The Alphabet Soup of Diabetes. Egils Bogdanovics M.D. Hungerford Diabetes Center

Chief of Endocrinology East Orange General Hospital

Dept of Diabetes Main Desk

Remote attendees, please mute your phones as a courtesy thank you!

7/8/2016. Sol Jacobs MD, FACE Division of Endocrinology Emory University School of Medicine

Glycemic Management of Type 2 Diabetes. Gail Nunlee-Bland, M.D. Professor Medicine & Pediatrics Director, Diabetes Treatment Center Howard University

Healthy You: A Guide to Diabetes Self-Care SURVIVAL SKILLS

Treatment Options for Diabetes: An Update

New Medications and Prescribing Methods for Diabetic Patients

Diabetes School October 2016

Pancreatic b-cell Dysfunction in Type 2 Diabetes ZIAD KAHWASH, M.D. Insulin resistance: Defects in Insulin Signaling

Welcome to the PHASE Learning Community! October 31, 2018

continuing education for pharmacists

Glucose Control drug treatments

Collaborative Practice Agreement

JACK L. SNITZER,D.O. Internal Medicine Board Review Course 2018 ENDOCRINE PANCREAS

Diabetes, Drugs and Dangerous Discrepancies. Sally Bodenhamer, OD, OT/L, CDE

3/16/2015. Improving the Management of Diabetes. W21 Angie Edmonds, PharmD, CGP Lorinda Babb, PharmD, CGP. Speaker Contact Information

Let s not sugarcoat it! Update on Pharmacologic Management of Type II DM

YOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013

Transcription:

Diabetes Management: A diagnostic perspective Images: http://www.engadget.com/2009/09/23/bayer-introduces-countour-usb-glucose-meter/ http://www.medtronicdiabetes.com/treatment-and-products/minimed-530g-diabetes-system-with-enlite http://www.accu-chek.com/microsites/nano/free-skin/index.html?source=cvs

Type 1 diabetes 5-10% of all diabetes More common in children and young adults, but possible at any age Immune system destroys pancreatic beta cells that produce insulin (dx=gad antibodies +, c-peptide -) Insulin replacement is required

Type 2 diabetes 90-95% of cases More common in adults, but increasingly seen in younger age groups Tissues not responding to insulin or not taking in glucose like before ( insulin-resistance ) Pancreas compensates by increasing insulin production, but gradually loses ability to produce more The body (usually the liver) makes too much glucose Oral meds often first tx, but insulin replacement may ultimately be needed

Diagnosis & Screening http://diabetes.niddk.nih.gov/dm/pubs/diagnosis/#3

Insulin types: Basal Drug Names Onset Peak Duration NPH (Novolin) Glargine (Lantus) Detemir (Levemir) Degludec 2-4 hours 4-8 hours 8-18 hours 4-5 hours None 22-24 hours 2 hours 6-8 hours 14-24 hours ~36 hours Image: http://www.diabetes.org/living-with-diabetes/treatment-and-care/medication/insulin/

Insulin types: Prandial Drug Names Onset Peak Duration Regular Lispro (Humalog) Aspart (Novolog) Glulisine (Apidra) 30-60 min 2-3 hours 4-8 hours 15-30 min 1-2 hours 3-6 hours 15-30 min 1-2 hours 3-6 hours 15-30 min 1-2 hours 3-6 hours Image: http://www.diabetes.org/living-with-diabetes/treatment-and-care/medication/insulin/

Medicines for type 2 diabetes Drug Names Primary Site of Action and Drug Class Mechanism of Action Route Possible Adverse Effects Metformin (Glucophage) Liver Biguanide Decreases amount of glucose the liver releases into bloodstream; May help reduce insulin resistance Orally Nausea, vomiting, diarrhea, gas (can minimize effects by slowly increasing dose) Glyburide Glipizide Repaglinide (Prandin) Pancreas Insulin secretagogues Helps the pancreas release more insulin Orally Hypoglycemia Nateglinide (Starlix) Exenatide (Byetta, Bydureon) Liraglutide (Victoza) Pancreas, Liver, Gut Incretin Increases satiety, Promotes pancreas release of adequate insulin; Prevents overproduction of glucose in the liver; Slows movement of food out of the gut; Subcutaneously Nausea, vomiting, hypoglycemia

Medicines for type 2 diabetes Drug Names Sitagliptin (Januvia) Saxagliptin (Onglyza) Primary Site of Action and Drug Class Pancreas, Liver DPP-IV inhibitor Mechanism of Action Route Possible Adverse Effects Reduced degradation of GLP-1 (see GLP-1 MOAs) Orally No major side effects, possible cold symptoms Rosiglitazone (Avandia) Pioglitazone (Actos) Muscle Thiazolidine-diones (TZDs) Improves the ability of muscle and other cells to use insulin Orally Weight gain, swelling, lipid increases Acarbose (Precose) Miglitol (Glyset) Gut Alpha glucosidase inhibitors Slows breakdown of carbohydrates from food Orally Diarrhea, gas, nausea (can minimize effects by slowly increasing dose) Canagliflozin (Invokana) Dapagliflozin (Farxiga) Kidney SGLT2 inhibitors Inhibits glucose reabsorption in the kidney, resulting in urinary glucose excretion Orally UTIs, renal impairment

Case Alice is a 58yo female with T2DM and heart failure. She comes to the clinic for help managing these conditions. She takes metformin 1000 mg daily, NPH 50units SC am and pm, and Novolog 8-10units before meals. Labs: BUN 1, Scr 1, egfr 57 ml/min) You download her glucometer data and print the results. Image: http://www.goodtoknow.co.uk/wellbeing/170914/are-home-test-kits-worth-it--diabetes

Questions about Alice s meter data What is the target range for normal glucose control? What trends do you see? Do you see episodes of hypoglycemia?

Case Rick is a 65yo male, and has been coming to the clinic for help managing his type 2 diabetes. He takes Lantus 40 units SC in the evenings, and Humalog 4-6 units at meals. You download his glucometer data and print the results. Image: http://diabetestrustfoundation.org/diabetes-and-health-insurance.php

Questions about Rick s meter data What trends do you see? Do you see episodes of hypoglycemia? From the table, why is standard deviation relevant?

Case Kevin is a 36yo male, an avid mountaineer, who plans to summit Mt. Rainier. He has type 1 diabetes, and wants to talk about what an appropriate glucometer option would be for him. Image: http://www.summitpost.org/above-13k-ft-on-the-dc-route/65796

Questions about Kevin s case What things might you consider when selecting a glucometer for a patient? What about Kevin s lifestyle might influence your glucometer recommendation? What meter might be the best option for Kevin, considering his plans?

How does a glucometer work? Test strips containing glucose oxidase react with glucose in a blood droplet, and an electrode in the meter reads the flux of the reaction. The number reported corresponds to the signal strength so, the more glucose, the higher the number. Image: http://m.eet.com/media/1110369/freescalemeterfig1.jpg

Other glucometer technology: Glucose dehydrogenase meters Glucometers containing glucose dehydrogenase work in a similar way, but utilize an oxygenindependent process instead. Image: http://www.intechopen.com/books/dehydrogenases/amperometric-glucose-sensors-for-whole-blood-measurement-based-on-dehydrogenase-enzymes

Altitude and glucometer reliability Several studies have been done over the years to assess this Mixed results Many earlier studies report consistent inaccuracy of meters Dehydrogenase meters typically reported to perform better Some recent studies have not found a difference

Some references regarding altitude and glucometer assessment Diabetes Care. 1996 Dec;19(12):1430-3. Diabet Med. 2001 Sep;18(9):749-55. Diabetes Technol Ther. 2002;4(5):627-35. Diabetes Care. 2005 May;28(5):1261. J Med Eng Technol. 2007 Mar-Apr;31(2):152-6. PLoS One. 2010 Nov 12;5(11):e15485. doi: 10.1371/journal.pone.0015485 High Alt Med Biol. 2013 Sep;14(3):197-204. doi: 10.1089/ham.2013.1020. Marco Cardosi and Zuifang Liu (2012). Amperometric Glucose Sensors for Whole Blood Measurement Based on Dehydrogenase Enzymes, Dehydrogenases, Prof. Rosa Angela Canuto (Ed.), ISBN: 978-953-307-019-3, InTech, DOI: 10.5772/48491. Available from: http://www.intechopen.com/books/dehydrogenases/amperometric-glucose-sensors-for-wholeblood-measurement-based-on-dehydrogenase-enzymes

Insulin pump case Madeline is a 17yo female, who has just started coming to the clinic for help managing her type 1 diabetes. She wears an insulin pump and sensor, and says she s really starting to get the hang of using these. A= Pump system B= Infusion set C= Sensor D= Transmitter Image: http://www.diabetespharmacist.com/tags/insulin-pump/

Questions about Madeline s case What type of patients would be good candidates for pump therapy? What device-related concerns would you have to consider with a pump? What other counseling points would be pertinent to cover with Madeline?